SEC Filing Summary: Zapata Corporation (10-Q)
Business Context and Reporting Period
This is a Quarterly Report on Form 10-Q for Zapata Corporation for the period ended March 31, 2003. Zapata is a holding company with two primary subsidiaries: Omega Protein Corporation (60% owned), the nation's largest marine protein company producing fish meal and oil, and Zap.Com Corporation (98% owned), a public shell corporation with no active operations. Zapata Corporate is actively exploring strategic transactions, including potential acquisitions or a sale of Omega Protein.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 |
|---|---|---|
| Revenues | $25.1 million | $23.5 million |
| Gross Profit | $6.4 million | $6.6 million |
| Operating Income | $2.7 million | $3.4 million |
| Net Income (Common Stockholders) | $0.75 million | $1.22 million |
| Diluted EPS | $0.31 | $0.51 |
| Cash & Equivalents | $45.0 million | $59.2 million |
| Short-term Investments | $78.2 million | $35.9 million |
| Total Debt | $15.2 million | $15.5 million |
| Operating Cash Flow | $10.2 million | $9.5 million |
Note: All figures in millions unless otherwise noted. Debt is primarily held by Omega Protein.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 7% to $25.1 million, driven by an 8% increase in Omega Protein's fish meal sales prices and a 9% volume increase, partially offset by a 15% decrease in fish oil volumes.
- Profitability Decline: Net income available to common stockholders decreased 39% to $0.75 million. This was caused by decreased gross profit at Omega Protein (due to higher cost inventories carried from 2002) and increased Selling, General, and Administrative (SG&A) expenses.
- Expense Increases: SG&A expenses rose 18% ($548,000 increase), primarily due to a shift from pension income to pension expense at Zapata Corporate ($142,000 expense vs. $161,000 income prior year) and increased legal/professional fees.
- Liquidity Shift: Cash and cash equivalents decreased by $35.6 million, largely due to a net increase in short-term investments ($42.2 million net purchase) and capital expenditures.
Outlook, Risks, and Contingencies
- Capital Expenditures: Omega Protein committed to a $16 million project to build a new fish oil processing facility in Reedville, Virginia, with construction starting May 2003. Funding is expected from available cash balances.
- Strategic Review: Management is authorized to explore strategic transactions involving Omega Protein, including increasing ownership or a sale/merger. No agreements have been reached as of the filing date.
- Legal Proceedings:
- Energy Industries Litigation: Three cases involving a 1996/1997 gas plant explosion. The primary insurance carrier has disclaimed coverage, though Zapata disputes this. Management believes losses will not be material.
- Shareholder Class Action: A lawsuit filed in March 2003 alleges breach of fiduciary duty regarding a purported $45-$50/share acquisition offer from a third party. Zapata denies the offer ever existed and has moved to dismiss.
- Market Risks: Omega Protein faces price volatility in fish meal and oil markets. Insurance costs are rising, potentially leading to higher deductibles and self-retention risks.
Investor Verification Checklist
- Insurance Coverage Status: Verify the outcome of the declaratory judgment action regarding the primary insurance carrier's refusal to cover the Energy Industries litigation.
- Strategic Transaction Progress: Monitor for updates on the potential sale or restructuring of Omega Protein, as this is a primary value driver for Zapata.
- Capital Project Execution: Track the $16 million fish oil facility construction timeline and funding sources to ensure no unexpected debt issuance is required.
- Shareholder Litigation: Review the May 12, 2003 motion argument regarding the class action suit alleging a rejected acquisition offer.
- Pension Assumptions: Assess the impact of fluctuating market interest rates on Zapata Corporate's pension expense, which significantly impacted Q1 2003 results.